% | $
Quotes you view appear here for quick access.

Sinovac Biotech Ltd. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • aabdo aabdo Nov 3, 2009 4:33 PM Flag

    北京科兴再获甲流疫苗订单 将全力完成生产任务

    Here is the English translation, using translator

    (Voice of the Straits Liu's north, special correspondent reporting from Beijing Liang Dong) has, Beijing Sinovac Biotech Co., Ltd. was re-issued by a stream of national vaccine orders. It is learned that, to December 12, 2009, the company should complete the 5.19 million Influenza A H1N1 influenza vaccine production tasks. This Kexing side said it will try to complete the task of a flow of vaccine production.
    Currently, Beijing is in accordance with informed consent, voluntary, free of charge in principle, there are plans for students, seniors, social and public service personnel category 5 priority groups, active vaccination Influenza H1N1 influenza vaccine in mid-November to complete primary and secondary school and social public service personnel of the vaccination, followed by the elderly and chronically ill patients to start vaccination. Beijing Sinovac Biotech Co., Ltd. Deputy General Manager of Wang Nan, based on current production tasks, all influenza production workshop and the corresponding auxiliary branch in overtime, based on the differences in mandates, individual processes and even arranged for three classes a 24-hour work. Kexing company will make every effort to complete the vaccine production tasks.
    From the vaccinated population monitoring point of view, a stream in full compliance with the safety of the vaccine standards, no cases of severe adverse reactions. Wang Nan said that, technically, the current vaccine is not produced by a flow of new technologies, but using the same and seasonal influenza vaccine technology, while the seasonal influenza vaccine has been used for many years, it is proved that the process of production out of the vaccine is safe and effective.

5.90-0.19(-3.12%)2:48 PMEDT